Lv4
720 积分 2021-08-20 加入
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis
2个月前
已完结
B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities
2个月前
已完结
GDF15 in the tumor microenvironment: a central mediator of cancer immunometabolism and therapeutic resistance
3个月前
已完结
Combination targeted therapy with two biologic/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy
4个月前
已完结
Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy
4个月前
已完结
NAMPT: A critical driver and therapeutic target for cancer
4个月前
已完结
Targeted degradation of extracellular secreted and membrane proteins
5个月前
已完结
The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
5个月前
已完结
Development and characterization of a fully human antibody targeting SCF/c-kit signaling
5个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
5个月前
已完结
皖公网安备34019202002308
